Cellectar Biosciences Inc (CLRB)
2.03
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
2.035
0.00 (0.00%)
After-Hours: 20:00
Cellectar Biosciences Price to Book Value: 18.15 for Nov. 4, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 18.15 |
| November 01, 2024 | 18.15 |
| October 31, 2024 | 18.24 |
| October 30, 2024 | 18.33 |
| October 29, 2024 | 18.33 |
| October 28, 2024 | 18.33 |
| October 25, 2024 | 18.15 |
| October 24, 2024 | 16.59 |
| October 23, 2024 | 16.12 |
| October 22, 2024 | 16.75 |
| October 21, 2024 | 16.67 |
| October 18, 2024 | 16.51 |
| October 17, 2024 | 16.28 |
| October 16, 2024 | 16.43 |
| October 15, 2024 | 16.12 |
| October 14, 2024 | 16.43 |
| October 11, 2024 | 16.75 |
| October 10, 2024 | 16.59 |
| October 09, 2024 | 16.12 |
| October 08, 2024 | 16.83 |
| October 07, 2024 | 16.91 |
| October 04, 2024 | 17.38 |
| October 03, 2024 | 17.07 |
| October 02, 2024 | 17.07 |
| October 01, 2024 | 16.43 |
| Date | Value |
|---|---|
| September 30, 2024 | 16.91 |
| September 27, 2024 | 16.12 |
| September 26, 2024 | 15.09 |
| September 25, 2024 | 15.17 |
| September 24, 2024 | 15.80 |
| September 23, 2024 | 15.72 |
| September 20, 2024 | 16.35 |
| September 19, 2024 | 16.67 |
| September 18, 2024 | 16.59 |
| September 17, 2024 | 16.67 |
| September 16, 2024 | 16.43 |
| September 13, 2024 | 16.83 |
| September 12, 2024 | 16.67 |
| September 11, 2024 | 16.51 |
| September 10, 2024 | 16.75 |
| September 09, 2024 | 16.83 |
| September 06, 2024 | 16.43 |
| September 05, 2024 | 16.59 |
| September 04, 2024 | 16.91 |
| September 03, 2024 | 16.91 |
| August 30, 2024 | 17.38 |
| August 29, 2024 | 17.30 |
| August 28, 2024 | 17.38 |
| August 27, 2024 | 17.38 |
| August 26, 2024 | 17.14 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.828
Minimum
May 12 2022
23.86
Maximum
Jul 22 2024
3.933
Average
1.938
Median
Price to Book Value Benchmarks
| Perspective Therapeutics Inc | 2.410 |
| Actinium Pharmaceuticals Inc | 1.251 |
| Chimerix Inc | 0.5704 |
| Marinus Pharmaceuticals Inc | -- |
| Jaguar Health Inc | 0.5684 |
Price to Book Value Related Metrics
| Price | 2.03 |
| Earnings Yield | -152.2% |
| Market Cap | 82.35M |